Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in GTBP — GT Biopharma, Inc.

CIK 19617 NEW YORK, NY
Back to GTBP Full portfolio

Position in GTBP

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
21 quarters on record

Common Shares in GTBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,192 across 425 Biotechnology names. GTBP ranks #425 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in GTBP

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $0 1
2026-03-31 $0 1
2025-12-31 $1 1
2025-09-30 $1 1
2025-06-30 $3 1
2025-03-31 $2 1
2024-12-31 $3 1
2024-09-30 $2 1
2024-06-30 $2 1
2024-03-31 $4 1
2023-12-31 $4 16
2023-09-30 $13 59
2023-06-30 $809 2,597
2023-03-31 $8 16
2022-12-31 $14 16
2022-09-30 $28 16
2022-06-30 $47 16
2022-03-31 $24,013 8,338
2021-12-31 $20,839 6,833
2021-09-30 $46,053 6,833
2021-06-30 $141,902 9,155